Clinical Trials Browser

Esophageal Squamous Cell Carcinoma

Hepatic Artery Infusion

Esophageal Squamous Cell Carcinoma

Advanced Solid Tumor

Esophageal Neoplasms

Esophageal Neoplasms

Resectable Lung Non-Small Cell Carcinoma

Head and Neck Neoplasms

Esophageal Squamous Cell Carcinoma

Hypopharyngeal Neoplasms

Esophageal Squamous Cell Carcinoma

Immunotherapy Esophagus Cancer

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck

Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

Advanced Non-squamous Non-Small-Cell Lung Cancer

Squamous Cell Carcinoma of Head and Neck

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Esophageal Squamous Cell Carcinoma

Esophageal Neoplasms

Esophageal Squamous Cell Carcinoma

Nasopharyngeal Carcinoma, Recurrence

Esophageal Neoplasms

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Ovarian Neoplasms, Recurrence, Stomach Neoplasms, Small Cell Lung Carcinoma

Esophageal Neoplasms

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Carcinoma, Squamous Cell

Nasopharyngeal Carcinoma

Esophageal Neoplasms

Uterine Cervical Neoplasms

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Uterine Cervical Neoplasms

Esophageal Neoplasms

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Carcinoma, Non-Small-Cell Lung

Carcinoma, Squamous Cell, Esophageal Neoplasms

Clinical Trials

Ipromlimab and Tuvonralimab Combined With Albumin-Bound Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard Therapy

PPIO-004-EC001

A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma

A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC

Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas

Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC

Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer

Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma

Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma

Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC

Fruquintinib as First Line Treatment in Patients With Recurrent Esophageal Squamous Cell Carcinoma

Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer

SPBPDC

Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC

Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma

Nedaplatin in Treatment for Nasopharyngeal Carcinoma

Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma

SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer

Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail

Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma

An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors

Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer

NX-NPC

A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC

TCM

Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma

Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma

Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma

Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer

Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer

The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma

NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation

NPC-RCT-WCRT

Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)

CSAPPPCC

S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer

A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal Carcinoma

DO201001

Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer